Abstract
Background:Neonatal jaundiceis one of the main reasons for prolonged hospitalization in newborns, and its progress and treatment depends on serum bilirubin values. Phototherapy remains the mainstay of treatment of pathological jaundice in newborn babies. Though, transcutaneous bilirubinometer has been used as a screening device for measuring bilirubin, its role during phototherapy has always been questioned. Objective: To study the correlation between Transcutaneous bilirubinometer (TcB) values with serum bilirubin levels (TSB) in infants during phototherapy in term and late preterm babies. Materials and Methods: The study was conducted in a tertiary new-born center from November 2014 to June 2016. The inclusion criteria included all babies above 34 weeks gestation and exclusion criteria included babies with established direct hyperbilirubinemia, neonatal septicemia, major congenital/ gastrointestinal malformations, and those on phototherapy.
Highlights
Neonatal jaundice or hyperbilirubinemia is observed during the first week of life in approximately 60% of term and 80% of preterm infants(1)
Transcutaneous bilirubinometer (TcB) and total serum bilirubin (TSB) showed good correlation (0.948) at 24 hrs of age before initiation of phototherapy but with a poor agreement
The correlation was better for TcBE and TSB within 24 hours of phototherapy, and as the duration increased, the correlation for TcBC was better than TCBE and serum bilirubin
Summary
Neonatal jaundice or hyperbilirubinemia is observed during the first week of life in approximately 60% of term and 80% of preterm infants(1). Neonatal hyperbilirubinemia occurs when there is an imbalance between the production and elimination of bilirubin, a breakdown product of study on inborn babies more than 34 weeks gestational age, from November 2014 to June 2016 in a neonatal unit of a medical college hospital in South India. The exclusion criteria included babies with established direct hyperbilirubinemia, neonatal septicemia, major congenital/ gastrointestinal malformations, and those started on phototherapy. The sample size was calculated using the formula: =. The clinical and dimorphic profile of the mother and the baby was collected using a proforma
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
